tirzepatide kidney (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Renal effects of GLP-1 receptor

In the past 15 years, GLP-1RAs have emerged as efficacious therapies in T2D and obesity, with evidence also indicating potential in CV disease and NASH

Several states, like South Carolina and California, have DUI laws that default to a breath test when only DUI alcohol is suspected

Curcumin offers potent anti-inflammatory and metabolic-supporting properties, while L-Carnitine L-Tartrate aids in efficiently converting stored fat into usable energy

This neuropathy can be particularly alarming because it affects your ability to feel and control your extremities

CagriSema vs Tirzepatide: Amylin/GLP-1 vs GIP/GLP-1 for Maximum Weight Loss Evidence-based comparison of CagriSema (amylin + GLP-1) and tirzepatide (GIP + GLP-1) for obesity, including REDEFINE and SURMOUNT trial data